Clinical Trials

NCT06356220 | RECRUITING | NA

120 Participants

GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2025-04-29

Completion: 2026-05-31

Conditions

Celiac Disease in Children Nutrition Disorder, Child

Interventions

OTHER

No Results Yet

NCT06353386 | RECRUITING | PHASE1/PHASE2

220 Participants

Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-05-20

Completion: 2029-01-15

Conditions

Prostatic Neoplasms, Castration-Resistant

Interventions

DRUG

No Results Yet

NCT06351644 | TERMINATED | PHASE1/PHASE2

2 Participants

ON 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-10-02

Completion: 2025-04-28

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG

No Results Yet

NCT06342986 | RECRUITING | PHASE1

33 Participants

Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-07-11

Completion: 2026-12-31

Conditions

Gynecologic Cancer Ovarian Cancer Fallopian Tube Cancer Primary Peritoneal Cavity Cancer

Interventions

DRUG

No Results Yet

NCT06338748 | ACTIVE_NOT_RECRUITING | NA

28 Participants

Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-11-02

Completion: 2025-10-01

Conditions

Continuous Glucose Monitoring

Interventions

DEVICE

No Results Yet

NCT06335303 | ACTIVE_NOT_RECRUITING | PHASE2

322 Participants

A Study to Test Whether BI 1819479 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-09-05

Completion: 2025-11-14

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG

No Results Yet

NCT06333652 | RECRUITING | PHASE2

14 Participants

Ravulizumab in Pregnancies Complicated by Severe Hypertensive Disorders

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2026-03-01

Completion: 2026-12-31

Conditions

Preeclampsia

Interventions

DRUG

No Results Yet

NCT06325683 | RECRUITING | PHASE2

184 Participants

Anti-Lag-3 (Relatlimab) and Anti-PD-1 Blockade (Nivolumab) Versus Standard of Care (Lomustine) for the Treatment of Patients With Recurrent Glioblastoma

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-11-08

Completion: 2028-07-15

Conditions

Progressive Glioblastoma Recurrent Glioblastoma

Interventions

PROCEDURE DRUG BIOLOGICAL

No Results Yet

NCT06324357 | RECRUITING | PHASE1/PHASE2

582 Participants

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-06-03

Completion: 2029-09-28

Conditions

Metastatic Breast Cancer Metastatic Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma

Interventions

DRUG

No Results Yet

NCT06317662 | RECRUITING | PHASE2

153 Participants

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2025-06-05

Completion: 2028-12-31

Conditions

Acute Leukemia of Ambiguous Lineage B Acute Lymphoblastic Leukemia

Interventions

DRUG PROCEDURE BIOLOGICAL

No Results Yet

NCT06317649 | RECRUITING | PHASE2

147 Participants

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-09-27

Completion: 2025-10-31

Conditions

Acute Myeloid Leukemia

Interventions

DRUG PROCEDURE

No Results Yet

NCT06317285 | TERMINATED | PHASE2

158 Participants

A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-04-04

Completion: 2025-10-01

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG

No Results Yet

NCT06287775 | RECRUITING | PHASE1/PHASE2

45 Participants

Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2025-04-08

Completion: 2029-07-25

Conditions

Extensive Stage Lung Small Cell Carcinoma Stage IV Lung Cancer AJCC v8

Interventions

BIOLOGICAL PROCEDURE DRUG

No Results Yet

NCT06286033 | RECRUITING | PHASE1

112 Participants

Single and Multiple Ascending Dose Study and Food Effect Study for AG181

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-02-20

Completion: 2026-03-31

Conditions

Healthy Volunteers

Interventions

DRUG

No Results Yet

NCT06283394 | ACTIVE_NOT_RECRUITING | NA

224 Participants

Penn Medicine Food Market Study

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-08-01

Completion: 2025-05-01

Conditions

Obesity Diabetes

Interventions

BEHAVIORAL

No Results Yet

NCT06257628 | WITHDRAWN

0 Participants

MACE CDS Software Master Enrollment Protocol

Study Type: OBSERVATIONAL

Last Updated: 2025-11-12

Start Date: 2023-09-14

Completion: 2025-05-31

Conditions

Cardiac Events

Interventions

DEVICE

No Results Yet

NCT06254326 | ACTIVE_NOT_RECRUITING | PHASE1

12 Participants

ADAGiO: Adoptive Cellular Therapy for the TreAtment of Recurrent OliGodendrogliOma (OG) Adult Patients

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-09-19

Completion: 2027-12-31

Conditions

Recurrent Oligodendroglioma Progressive Oligodendroglioma

Interventions

BIOLOGICAL DRUG

No Results Yet

NCT06246110 | RECRUITING | PHASE2

70 Participants

A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-02-06

Completion: 2026-12-31

Conditions

NSCLC

Interventions

DRUG

No Results Yet

NCT06227026 | RECRUITING | PHASE1

10 Participants

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-02-20

Completion: 2026-01-15

Conditions

Acute Lymphoblastic Leukemia Diffuse Large B Cell Lymphoma

Interventions

BIOLOGICAL

No Results Yet

NCT06226805 | RECRUITING | PHASE2

156 Participants

Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-07-31

Completion: 2027-06-30

Conditions

Acute Ischemic Stroke

Interventions

DRUG

No Results Yet

NCT06223555 | RECRUITING | NA

79 Participants

Variability In Mixed Meal Tests: Fixed Versus Adjusted to Energy Needs Caloric Dose

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-08-23

Completion: 2026-06-30

Conditions

Obesity Healthy Volunteer

Interventions

OTHER

No Results Yet

NCT06215118 | RECRUITING | PHASE1

87 Participants

A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-02-20

Completion: 2027-04-10

Conditions

Multiple Myeloma

Interventions

DRUG

No Results Yet

NCT06214741 | ACTIVE_NOT_RECRUITING | PHASE3

307 Participants

A Study to Test Whether Survodutide (BI 456906) Helps Chinese People Living With Overweight or Obesity to Lose Weight

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-02-06

Completion: 2025-07-29

Conditions

Obesity Overweight

Interventions

DRUG

No Results Yet

NCT06212752 | ACTIVE_NOT_RECRUITING | PHASE3

39 Participants

A Study of Subcutaneous (SC) Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) vs Intravenous Pembrolizumab in Adult Participants With Metastatic Non-small Cell Lung Cancer (NSCLC) (MK-3475A-D77)-Japan Extension

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2023-06-13

Completion: 2024-11-06

Conditions

Metastatic Non-small Cell Lung Cancer

Interventions

BIOLOGICAL DRUG

Results Available

NCT06206746 | RECRUITING | NA

195 Participants

The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-03-25

Completion: 2026-06-30

Conditions

Polycystic Ovary Syndrome Infertility, Female

Interventions

DEVICE

No Results Yet

NCT06195306 | RECRUITING | PHASE2

66 Participants

Low Dose Tamoxifen With or Without Omega-3 Fatty Acids for Breast Cancer Risk Reduction

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2025-04-01

Completion: 2027-10-01

Conditions

Breast Atypical Hyperplasia Breast Carcinoma Breast Ductal Carcinoma In Situ Breast Lobular Carcinoma In Situ

Interventions

PROCEDURE DRUG OTHER

No Results Yet

NCT06192160 | RECRUITING | PHASE2

315 Participants

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2025-03-11

Completion: 2026-11-11

Conditions

Pulmonary Tuberculosis

Interventions

DRUG

No Results Yet

NCT06191484 | RECRUITING | NA

169 Participants

Risk and Resilience to Suicide Following Late-Life Spousal Bereavement

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2023-11-20

Completion: 2028-12-31

Conditions

Suicide Bereavement

Interventions

BEHAVIORAL

No Results Yet

NCT06189807 | ACTIVE_NOT_RECRUITING | NA

70 Participants

Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-02-14

Completion: 2025-09-24

Conditions

CKD Chronic Kidney Diseases

Interventions

BEHAVIORAL OTHER

No Results Yet

NCT06176365 | ACTIVE_NOT_RECRUITING | PHASE3

274 Participants

A Study to Test Whether Survodutide Helps Japanese People Living With Obesity Disease

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-01-16

Completion: 2025-12-03

Conditions

Obesity

Interventions

DRUG

No Results Yet

NCT06173804 | ACTIVE_NOT_RECRUITING | NA

20 Participants

Multilevel Lifestyle Intervention to Improve Physical Function in Older Adults With Type 2 Diabetes

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-07-22

Completion: 2025-05-23

Conditions

Type 2 Diabetes

Interventions

OTHER

No Results Yet

NCT06164951 | ACTIVE_NOT_RECRUITING | PHASE3

110 Participants

A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2023-11-10

Completion: 2025-12-31

Conditions

Achondroplasia

Interventions

DRUG

No Results Yet

NCT06152575 | RECRUITING | PHASE3

492 Participants

MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-02-08

Completion: 2026-08-30

Conditions

Multiple Myeloma

Interventions

DRUG

No Results Yet

NCT06150417 | RECRUITING | PHASE2

200 Participants

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-07-01

Completion: 2028-04-01

Conditions

Prostate Cancer Malignant Neoplasm of Prostate Secondary Malignant Neoplasm of Prostate

Interventions

DRUG OTHER RADIATION

No Results Yet

NCT06139328 | ACTIVE_NOT_RECRUITING | PHASE2

160 Participants

IRI-EXPLORE: A Study to Test Whether BI 765845 Helps People Who Have Had a Heart Attack

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2023-12-05

Completion: 2025-09-02

Conditions

Myocardial Infarction

Interventions

DRUG

No Results Yet

NCT06136624 | RECRUITING | PHASE3

1310 Participants

Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2023-12-31

Completion: 2028-08-02

Conditions

Prostate Cancer Metastatic

Interventions

DRUG

No Results Yet

NCT06133634 | ACTIVE_NOT_RECRUITING | PHASE1/PHASE2

70 Participants

Fisetin to Improve Vascular Function in Older Adults

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2023-09-25

Completion: 2026-03-31

Conditions

Aging Endothelial Dysfunction Arterial Stiffness

Interventions

DIETARY_SUPPLEMENT OTHER

No Results Yet

NCT06132113 | RECRUITING | PHASE1

55 Participants

DAREON™-7: A Study to Test How Well Different Doses of BI 764532 in Addition to Chemotherapy Are Tolerated by People With Advanced Neuroendocrine Cancers

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-01-22

Completion: 2027-02-09

Conditions

Neuroendocrine Neoplasms

Interventions

DRUG

No Results Yet

NCT06128928 | RECRUITING | NA

900 Participants

Connecting Friends and Health Workers to Boost COVID-19 Vaccination in Latino Communities

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2023-07-08

Completion: 2026-12-31

Conditions

COVID-19 Vaccine

Interventions

BEHAVIORAL

No Results Yet

NCT06127407 | RECRUITING | PHASE3

136 Participants

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

Study Type: INTERVENTIONAL

Last Updated: 2025-11-12

Start Date: 2024-07-09

Completion: 2028-02-01

Conditions

Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen

Interventions

DRUG

No Results Yet